Incyte
INCY
#1110
Rank
NZ$34.83 B
Marketcap
NZ$177.46
Share price
2.05%
Change (1 day)
39.33%
Change (1 year)

Incyte (INCY) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$71.43 Million

According to Incyte's latest financial reports the company's total debt is NZ$71.43 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Incyte - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$77.2 M27.53%
2023-12-31NZ$60.54 M-7.28%
2022-12-31NZ$65.29 M-0.49%
2021-12-31NZ$65.61 M-0.39%
2020-12-31NZ$65.87 M-26.33%
2019-12-31NZ$89.42 M66.02%
2018-12-31NZ$53.86 M59.38%
2017-12-31NZ$33.79 M-96.41%
2016-12-31NZ$0.94 B3.84%
2015-12-31NZ$0.90 B5.11%
2014-12-31NZ$0.86 B7.04%
2013-12-31NZ$0.80 B100.04%
2012-12-31NZ$0.40 B-0.65%
2011-12-31NZ$0.40 B6.5%
2010-12-31NZ$0.38 B-37.66%
2009-12-31NZ$0.61 B-10.63%
2008-12-31NZ$0.68 B35.28%
2007-12-31NZ$0.50 B-4.2%
2006-12-31NZ$0.52 B5.32%
2005-12-31NZ$0.50 B-5.77%
2004-12-31NZ$0.53 B105.65%
2003-12-31NZ$0.25 B-21.48%
2002-12-31NZ$0.32 B-23.85%
2001-12-31NZ$0.43 B1.85%
2000-12-31NZ$0.42 B110642.63%
1999-12-31NZ$0.38 M-74.79%
1998-12-31NZ$1.51 M
1996-12-31NZ$0.14 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
NZ$94.49 B 132,177.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.78 B 992.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$73.57 B 102,903.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$105.32 B 147,349.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ$0.21 B 195.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.35 B 403.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$55.43 B 77,497.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
NZ$66.95 M-6.27%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ$84.63 M 18.48%๐Ÿ‡บ๐Ÿ‡ธ USA